In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 1.11 above Radnet Inc average.

Within Medical Laboratories industry 20 other companies have achieved higher Quick Ratio than Radnet Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1784 to 1882.

Explain Quick Ratio?
How much Cash & cash equivalents RDNT�s has?
What are RDNT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RDNT/financial-strength

https://api.csimarket.com/api/v1/companies/RDNT/fundamentals

https://api.csimarket.com/api/v1/companies/RDNT/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

RDNT Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	24.65 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-5.88 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	1.11	Subscribe	Subscribe	Subscribe	Subscribe
RDNT's Total Ranking	# 1882	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	2.7 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	3.15 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 21
Healthcare Sector	# 609
Overall Market	# 1882

Quick Ratio Statistics
High	Average	Low
1.69	0.43	0.03
(Sep 30 2024)		(Jun 30 2012)

Financial Statements
Radnet Inc 's Current Liabilities	$ 717 Millions	Visit RDNT's Balance sheet
Radnet Inc 's Cash & cash equivalent	$ 798 Millions	Visit RDNT's Balance sheet
Source of RDNT's Sales		Visit RDNT's Sales by Geography

Cumulative Radnet Inc 's Quick Ratio

RDNT's Quick Ratio for the trailling 12 Months

RDNT Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	25.01 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-11.6 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	1.09	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3989	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	5.68 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-1.7 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to RDNT Financial Strength Comparisons >> Go to Compare RDNT Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $716.64 millions, cumulative Quick Ratio decreased to 1.09 above the RDNT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 36 other companies have achieved higher Quick Ratio than Radnet Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3942 to 3989.

Explain Quick Ratio?
How much Cash & cash equivalents RDNT�s has?
What are RDNT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 37
Healthcare Sector	# 895
Within the Market	# 3989

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.61	0.42	0.03
(Mar 31 2025)		(Mar 31 2015)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Laboratories Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Guardant Health Inc	2.75	$ 1,026.848 Millions	$ 373.165 Millions
Incyte Corporation	2.68	$ 3,854.572 Millions	$ 1,437.818 Millions
Exagen Inc	2.14	$ 28.092 Millions	$ 13.100 Millions
Biodesix Inc	1.99	$ 28.409 Millions	$ 14.248 Millions
Caredx Inc	1.80	$ 250.480 Millions	$ 138.975 Millions
Butterfly Network Inc	1.80	$ 122.301 Millions	$ 67.987 Millions
Sera Prognostics Inc	1.80	$ 44.089 Millions	$ 24.527 Millions
Radnet Inc	1.11	$ 797.880 Millions	$ 716.642 Millions
Bioaffinity Technologies Inc	1.01	$ 2.550 Millions	$ 2.533 Millions
Quest Diagnostics Inc	0.49	$ 893.000 Millions	$ 1,834.000 Millions
Medpace Holdings Inc	0.47	$ 705.315 Millions	$ 1,496.097 Millions
Ge Healthcare Technologies Inc	0.32	$ 2,826.000 Millions	$ 8,815.000 Millions
Grail Inc	0.31	$ 29.394 Millions	$ 94.332 Millions
Iqvia Holdings Inc	0.31	$ 2,422.000 Millions	$ 7,777.000 Millions
Fortrea Holdings Inc	0.22	$ 220.600 Millions	$ 983.300 Millions

Date modified: 2026-11-10T09:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.